HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yamin Wei Selected Research

4'-methoxy-3',5,7-trihydroxyisoflavone

4/2022Pratensein Mitigates Oxidative Stress and NLRP3 Inflammasome Activation in OGD/R-Injured HT22 Cells by Activating Nrf2-Anti-oxidant Signaling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yamin Wei Research Topics

Disease

1Brain Ischemia (Cerebral Ischemia)
04/2022
1Hemolysis
03/2022
1Neoplasms (Cancer)
03/2022
1Infarction (Infarctions)
07/2019
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
07/2019
1Stroke (Strokes)
07/2019
1Cerebral Palsy (Spastic Diplegia)
01/2019
1Brain Injuries (Brain Injury)
01/2019
1Cerebral Infarction
07/2018
1Hypertension (High Blood Pressure)
07/2018

Drug/Important Bio-Agent (IBA)

14'-methoxy-3',5,7-trihydroxyisoflavoneIBA
04/2022
1Neuroprotective AgentsIBA
04/2022
1RH 160IBA
03/2022
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
07/2019
1ChloridesIBA
07/2019
1NADP (NADPH)IBA
07/2019
1Glutathione Disulfide (GSSG)FDA LinkGeneric
07/2019
1Protein Isoforms (Isoforms)IBA
07/2019
1X-Linked Inhibitor of Apoptosis ProteinIBA
01/2019
1fibrin fragment D (D-dimer)IBA
07/2018
1Brain Natriuretic Peptide (Natrecor)FDA Link
07/2018